Acetyl Tetrapeptide-5 vs Matrixyl
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Acetyl Tetrapeptide-5 or Matrixyl?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Acetyl Tetrapeptide-5 and Matrixyl?
Matrixyl stimulates collagen synthesis by mimicking collagen fragments that signal repair; Acetyl-tetrapeptide-5 targets vascular permeability for periorbital edema - pro-collagen vs. anti-edema mechanisms.
Evidence Comparison
Matrixyl (palmitoyl pentapeptide-4): independent studies including a published double-blind trial showing collagen I synthesis stimulation and wrinkle reduction. Acetyl-tetrapeptide-5: manufacturer data only. Matrixyl has meaningfully stronger evidence with independent validation.
Evidence Context Favoring Acetyl Tetrapeptide-5
Periorbital puffiness research specifically, accepting manufacturer-only evidence.
Evidence Context Favoring Matrixyl
Anti-wrinkle or collagen synthesis research where Matrixyl has independent human data and a more established mechanism.
Side-by-Side Snapshot
| Evidence grade | Acetyl Tetrapeptide-5: Level D Matrixyl: Level C |
|---|---|
| Research status | Acetyl Tetrapeptide-5: Preclinical Matrixyl: Preclinical |
| Primary category | Acetyl Tetrapeptide-5: Skin & Beauty Matrixyl: Skin & Beauty |
| Cited studies | Acetyl Tetrapeptide-5: 2 Matrixyl: 2 |